The value of harm reduction for injection drug use: A clinical and public health ethics analysis

L Vearrier - Disease-a-Month, 2019 - Elsevier
The US is facing dual public health crises related to opioid overdose deaths and HIV.
Injection drug use is fueling both of these epidemics. The War on Drugs has failed to stem …

Medication treatment for opioid use disorders in substance use treatment facilities

R Mojtabai, C Mauro, MM Wall, CL Barry, M Olfson - Health Affairs, 2019 - healthaffairs.org
Medication treatment (MT) is one of the few evidence-based strategies proposed to combat
the current opioid epidemic. We examined national trends and correlates of offering MT in …

Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder

EA Evans, D Wilson, PD Friedmann - Drug and alcohol dependence, 2022 - Elsevier
Background Buprenorphine is an effective medication for opioid use disorder (MOUD) when
offered in community-based settings, but evidence is limited for incarcerated populations …

[HTML][HTML] Economic evaluations of pharmacologic treatment for opioid use disorder: a systematic literature review

EN Onuoha, JA Leff, BR Schackman, KE McCollister… - Value in Health, 2021 - Elsevier
Objective The crisis of opioid use puts a strain on resources in the United States and
worldwide. There are 3 US Food and Drug Administration–approved medications for …

Cost-effectiveness of treatments for opioid use disorder

M Fairley, K Humphreys, VR Joyce… - JAMA …, 2021 - jamanetwork.com
Importance Opioid use disorder (OUD) is a significant cause of morbidity and mortality in the
US, yet many individuals with OUD do not receive treatment. Objective To assess the cost …

Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach

AM Bunting, CB Oser, M Staton, KS Eddens… - Addiction science & …, 2018 - Springer
Background The non-medical use of opioids has reached epidemic levels nationwide, and
rural areas have been particularly affected by increasing rates of overdose mortality as well …

Women-reported barriers and facilitators of continued engagement with medications for opioid use disorder

A Fiddian-Green, A Gubrium, C Harrington… - International Journal of …, 2022 - mdpi.com
Opioid-related fatalities increased exponentially during the COVID-19 pandemic and show
little sign of abating. Despite decades of scientific evidence that sustained engagement with …

Substance involvement and probation outcomes: Evidence from a cohort study

MA Galvin, KM Davidson… - Journal of Drug Issues, 2022 - journals.sagepub.com
Substance use disorders are common among justice-involved populations, the majority of
whom are under community supervision in the form of probation. Substance involvement …

Cost-effectiveness of publicly funded treatment of opioid use disorder in California

E Krebs, B Enns, E Evans, D Urada… - Annals of internal …, 2018 - acpjournals.org
Background: Only 1 in 5 of the nearly 2.4 million Americans with an opioid use disorder
received treatment in 2015. Fewer than half of Californians who received treatment in 2014 …

Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder

B Enns, E Krebs, DGT Whitehurst… - Drug and Alcohol …, 2023 - Elsevier
Background Our objective was to examine the cost-effectiveness of flexible take-home
buprenorphine-naloxone (BNX) versus methadone alongside the OPTIMA trial in Canada …